2h96 image
Deposition Date 2006-06-09
Release Date 2006-07-25
Last Version Date 2023-08-30
Entry Detail
PDB ID:
2H96
Keywords:
Title:
Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide C-jun NH2-terminal Kinase Inhibitors
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
(Taxon ID: )
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.27
R-Value Work:
0.22
R-Value Observed:
0.24
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase 8
Gene (Uniprot):MAPK8
Mutations:T183E,Y183E
Chain IDs:A, C (auth: B)
Chain Length:370
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:C-jun-amino-terminal kinase-interacting protein 1
Gene (Uniprot):MAPK8IP1
Chain IDs:B (auth: F), D (auth: G)
Chain Length:11
Number of Molecules:2
Biological Source:
Primary Citation

Abstact

C-Jun NH2 terminal kinases (JNKs) are important cell signaling enzymes. JNK1 plays a central role in linking obesity and insulin resistance. JNK2 and JNK3 may be involved in inflammatory and neurological disorders, respectively. Small-molecule JNK inhibitors could be valuable tools to study the therapeutic benefits of inhibiting these enzymes and as leads for potential drugs targeting JNKs. In this report, we disclose a series of potent and highly selective JNK inhibitors with good pharmacokinetic profiles.

Legend

Protein

Chemical

Disease

Primary Citation of related structures